Becton Dickinson

Becton, Dickinson and Company (BD) stands as one of the world's leading medical technology companies, with a rich heritage spanning more than 125 years. Founded in 1897, BD has evolved from a small New York-based medical device manufacturer into a global powerhouse ranked #211 on the 2024 Fortune 500 list, with annual revenues exceeding $21.8 billion in fiscal 2025.

BD operates through three strategic divisions that together create a comprehensive portfolio of medical solutions. BD Medical, representing nearly half of total revenue, manufactures essential medical supplies including IV catheters, syringes, advanced needle technologies, and medication management solutions. BD Life Sciences develops diagnostic solutions, microbiology systems, and laboratory equipment for infectious disease detection and research. BD Interventional focuses on advanced patient monitoring, interventional cardiology, and peripheral vascular disease treatments.

The company serves healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical companies, and the general public across more than 190 countries. BD's manufacturing footprint includes facilities throughout the United States, Europe, and Asia, with a workforce of approximately 74,000 employees as of September 2024. The company has invested over $1.2 billion in research and development annually, driving innovation in medical discovery, diagnostics, and care delivery.

In recent years, BD has undergone significant strategic transformation. The 2024 acquisition of Edwards Lifesciences' critical care unit for $4.2 billion strengthened BD's position in advanced patient monitoring. In 2025, BD announced a $17.5 billion Reverse Morris Trust deal with Waters Corporation to merge its Biosciences and Diagnostic Solutions divisions into a new independent company, allowing BD to sharpen its focus on core medical device businesses. This strategic realignment positions BD to advance its mission of improving medical discovery, diagnostics, and the delivery of care worldwide.

BD's commitment to innovation, quality, and improving patient outcomes has made it an indispensable partner to healthcare systems globally, touching millions of lives daily through products that enhance safety, increase efficiency, and enable better clinical outcomes.